Online users said the protest was over wages and layoffs at the manufacturer, Zybio, in the central municipality of Chongqing. Read more at straitstimes.com.
SHANGHAI - Protesters clashed with police in central China during a demonstration on Saturday by hundreds of people at a factory producing Covid-19 antigen kits, several videos posted to social media showed.
Reuters was unable to obtain any immediate comment from Zybio, but verified, via geolocation, that some of videos were filmed at the company’s factory in Chongqing. A person who answered a phone call at Zybio’s headquarters declined to comment on Sunday. Emails to the company were not immediately answered.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Travel curbs rack up as COVID-hit China readies reopeningSHANGHAI/BEIJING: More countries around the world are demanding that visitors from China take COVID-19 tests, days before it drops border controls and ushers in an eagerly awaited return to travel for
続きを読む »
Netherlands, Portugal require COVID-19 tests for China arrivalsTHE HAGUE: The Dutch and Portuguese governments on Friday (Jan 6) joined a growing number of nations requiring air passengers arriving from China to show a negative COVID-19 test upon entry. More than a dozen countries have slapped fresh travel regulations on travellers from the world's most populous natio
続きを読む »
China in talks with Pfizer for generic Covid-19 drug: SourcesBeijing is keen to finalise licensing deal terms before the Lunar New Year which begins on Jan 22. Read more at straitstimes.com.
続きを読む »
China’s Covid-19 surge threatens villages as Chinese New Year approachesChina is bracing for an onslaught of infections in its fragile countryside. Read more at straitstimes.com.
続きを読む »
China-made mRNA COVID-19 vaccine starts trial productionSHANGHAI: China's CanSino Biologics has entered the 'test production phase' for its COVID-19 mRNA booster vaccine, the company said in a post on its social media account late on Thursday (Jan 5). The vaccine, known as CS-2034, targets new Omicron variants of the virus, which are responsible for the vast ma
続きを読む »
China in talks with Pfizer for generic Covid-19 drug: SourcesHONG KONG/BEIJING – China is in talks with Pfizer Inc to secure a licence that will allow domestic drugmakers to manufacture and distribute a generic version of the US firm's Covid-19 antiviral drug Paxlovid in China, three sources told Reuters. China's medical products regulator – the National Medical Products Administration (NMPA) – has been leading the talks with Pfizer since...
続きを読む »